GlassScriptPhysician profile
Calvin Ryan Williams
NPI 1932664414
$1,078.50
in general payments reported to CMS, 2019-2025
12 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $570 · 2024: $222 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.50 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $372.44 | 2023-2025 | Zepbound |
| Integra Lifesciences Corporation | $164.19 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Astellas Pharma US INC | $115.50 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $96.61 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $78.78 | 2023-2025 | Slynd |
| Hologic Sales and Service, LLC | $60.25 | 2024-2025 | Fluent Fluid Management System, Novasure, Thinprep 2000 Processor |
| Sage Therapeutics, LLC | $57.67 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $54.78 | 2024 | |
| Pfizer INC. | $24.47 | 2025 | |
| Organon LLC | $21.16 | 2025 | Nexplanon |
| Millicent US INC | $19.68 | 2024 | Intrarosa |
| Mayne Pharma Commercial LLC | $12.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calvin Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.